Latest Articles

Publication Date
Global epidemiology of ovarian cancer: patterns, trends, and risk factors.

Ovarian cancer was the eighth most frequently diagnosed cancer among women in 2022. The global age-standardized incidence rate of ovarian cancer decreased from 7.22/100,000 to 6.71/100,000 from 1990 to 2021. …

Published: March 24, 2026, midnight
Endometrial epithelial cells with high ALDH activity control uterine development and regeneration.

Adult stem cells are thought to drive the regenerative potential of the endometrium and contribute to the pathogenesis of endometriosis, however, their identity and defining features remain to be characterized. …

Published: March 24, 2026, midnight
Extra-uterine Endometrial Stromal Sarcoma of the Stomach Mimicking a Gastrointestinal Stromal Tumour: A Case Report - Cureus

Extra-uterine Endometrial Stromal Sarcoma of the Stomach Mimicking a Gastrointestinal Stromal Tumour: A Case Report Cureus

Published: March 23, 2026, 7:25 p.m.
Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' - Daily Mail

Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' Daily Mail

Published: March 23, 2026, 4:17 p.m.
Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' - dailymail.co.uk

Fury as trans woman is appointed to represent an endometriosis charity - who say condition 'affects people of all genders' dailymail.co.uk

Published: March 23, 2026, 4:17 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
Outrage after transgender woman appointed as endometriosis charity representative - MSN

Outrage after transgender woman appointed as endometriosis charity representative MSN

Published: March 23, 2026, 11:08 a.m.
Trans Row: Outrage as transgender woman appointed as endometriosis charity representative - GB News

Trans Row: Outrage as transgender woman appointed as endometriosis charity representative GB News

Published: March 23, 2026, 9:32 a.m.
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease - Baishideng Publishing Group

Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease Baishideng Publishing Group

Published: March 23, 2026, 8:02 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!